144 related articles for article (PubMed ID: 10801249)
1. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
[TBL] [Abstract][Full Text] [Related]
3. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
[TBL] [Abstract][Full Text] [Related]
4. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
[TBL] [Abstract][Full Text] [Related]
6. 6β-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study.
Yancey-Wrona J; Dallaire B; Bilsky E; Bath B; Burkart J; Webster L; Magiera D; Yang X; Phelps M; Sadee W
Pain Med; 2011 Dec; 12(12):1727-37. PubMed ID: 22123184
[TBL] [Abstract][Full Text] [Related]
7. Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
Yuan CS; Doshan H; Charney MR; O'connor M; Karrison T; Maleckar SA; Israel RJ; Moss J
J Clin Pharmacol; 2005 May; 45(5):538-46. PubMed ID: 15831777
[TBL] [Abstract][Full Text] [Related]
8. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
[TBL] [Abstract][Full Text] [Related]
10. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
Murphy DB; Sutton JA; Prescott LF; Murphy MB
Anesthesiology; 1997 Oct; 87(4):765-70. PubMed ID: 9357876
[TBL] [Abstract][Full Text] [Related]
11. Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone.
Moss J
Anesthesiology; 2019 Jan; 130(1):142-148. PubMed ID: 30277930
[TBL] [Abstract][Full Text] [Related]
12. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
[TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone prevents morphine-induced kaolin intake in the rat.
Aung HH; Mehendale SR; Xie JT; Moss J; Yuan CS
Life Sci; 2004 Apr; 74(22):2685-91. PubMed ID: 15043984
[TBL] [Abstract][Full Text] [Related]
15. Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.
Franchi F; Rollini F; Park Y; Hu J; Kureti M; Rivas Rios J; Faz G; Yaranov D; Been L; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2019 Aug; 12(16):1538-1549. PubMed ID: 31377269
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylnaltrexone on morphine-induced cough suppression in guinea pigs.
Foss JF; Orelind E; Goldberg LI
Life Sci; 1996; 59(15):PL235-8. PubMed ID: 8845013
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.
Yuan CS; Foss JF; O'Connor M; Osinski J; Roizen MF; Moss J
Drug Alcohol Depend; 1998 Oct; 52(2):161-5. PubMed ID: 9800145
[TBL] [Abstract][Full Text] [Related]
18. The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants.
Brokjaer A; Olesen AE; Christrup LL; Dahan A; Drewes AM
Neurogastroenterol Motil; 2015 May; 27(5):693-704. PubMed ID: 25810023
[TBL] [Abstract][Full Text] [Related]
19. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
20. Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.
Martin-Flores M; Singh B; Walsh CA; Brooks EP; Taylor L; Mitchell LM
J Am Assoc Lab Anim Sci; 2017 Mar; 56(2):155-159. PubMed ID: 28315644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
